08:00 , Feb 1, 2016 |  BC Week In Review  |  Company News

EpiVax, Schroedinger deal

EpiVax and Schrodinger spun out virtual JV, Aceno Biotherapeutics , which will use computational tools to develop a portfolio of “biobetter” therapeutics that will be “immune-engineered” by EpiVax. Aceno will combine EpiVax’s immunoinformatics toolbox and...